• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Excitation dependent recombination studies on SnO2/TiO2 electrospun nanofibers?
  Veluru Jagadeesh babu,Sesha Vempati RSC Adv., 2015,5, 66367-66375
• 5. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpropanes

Chemical Profile of 2-methyl-1-(3-methylphenyl)propan-1-amine (CAS No. 854184-33-1)

2-methyl-1-(3-methylphenyl)propan-1-amine, identified by the Chemical Abstracts Service registry number 854184-33-1, is a significant compound in the realm of organic chemistry and pharmaceutical research. This molecule, featuring a structural framework that combines an amine functional group with aromatic and aliphatic moieties, has garnered attention due to its potential applications in medicinal chemistry and synthetic methodologies. The presence of a tertiary amine and a methyl-substituted benzene ring contributes to its unique chemical properties, making it a subject of interest for researchers exploring novel pharmacophores.

The synthesis of 2-methyl-1-(3-methylphenyl)propan-1-amine involves multi-step organic reactions that highlight the compound's complexity. Typically, the preparation begins with the Friedel-Crafts alkylation of 3-methylbenzene (m-xylene) to introduce an alkyl group, followed by nucleophilic substitution or reduction steps to incorporate the amine functionality. The precise control of reaction conditions, such as temperature and catalyst selection, is crucial to achieving high yields and purity. Advanced techniques like chromatography and spectroscopic methods are employed to isolate and characterize the final product, ensuring compliance with stringent quality standards.

In recent years, 2-methyl-1-(3-methylphenyl)propan-1-amine has been studied for its role as an intermediate in the development of bioactive molecules. Its structural motif is reminiscent of several pharmacologically relevant compounds, suggesting potential applications in drug discovery. For instance, analogs containing similar scaffolds have been investigated for their effects on neurotransmitter systems, including serotonin and dopamine receptors. While direct clinical applications of this specific compound remain under exploration, its derivatives offer a promising starting point for designing molecules with enhanced binding affinity and selectivity.

The compound's physicochemical properties, such as solubility and stability, are also areas of active investigation. These properties dictate its suitability for various formulations and delivery systems. Researchers have experimentally determined that 2-methyl-1-(3-methylphenyl)propan-1-amine exhibits moderate solubility in organic solvents like ethanol and dichloromethane but limited solubility in water. This characteristic influences its handling and potential use in aqueous-based pharmaceutical formulations, necessitating further modifications or co-solvent systems to improve bioavailability.

Computational chemistry has played a pivotal role in understanding the behavior of 2-methyl-1-(3-methylphenyl)propan-1-amine at the molecular level. Molecular modeling studies have provided insights into its interactions with biological targets, helping predict binding modes and affinity. These simulations are complemented by experimental validations using techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy. The integration of computational and experimental data has accelerated the design process for drug-like molecules derived from this scaffold.

The environmental impact of synthesizing and handling 2-methyl-1-(3-methylphenyl)propan-1-amine is another consideration in modern chemical research. Efforts are underway to develop greener synthetic routes that minimize waste and hazardous byproducts. Catalytic processes and solvent-free reactions are being explored as alternatives to traditional methods. Such advancements not only enhance sustainability but also reduce costs associated with purification and waste disposal.

Future directions for research on 2-methyl-1-(3-methylphenyl)propan-1-amine include exploring its role in modulating enzyme activity and cellular pathways relevant to neurological disorders. Preclinical studies are being planned to assess its efficacy in animal models, providing a foundation for potential human trials. Collaborations between academic institutions and pharmaceutical companies are expected to drive these efforts forward, leveraging expertise in medicinal chemistry and pharmacology.

The compound's versatility as a building block for more complex molecules cannot be overstated. Chemists have utilized it to construct libraries of derivatives for high-throughput screening (HTS), identifying novel bioactive entities with therapeutic potential. This approach aligns with current trends in drug discovery, where combinatorial chemistry and structure-based design streamline the identification of lead compounds.

In summary, 2-methyl-1-(3-methylphenyl)propan-1-amine (CAS No. 854184-33-1) represents a fascinating subject of study within organic chemistry and pharmaceutical science. Its unique structural features, coupled with ongoing research into its applications, position it as a valuable asset in the quest for new medicines. As methodologies evolve toward greater efficiency and sustainability, this compound will likely continue to play a significant role in advancing chemical biology and therapeutic innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)